Kanabo Group Plc (LON: KNB)

London flag London · Delayed Price · Currency is GBP · Price in GBX
0.822
-0.028 (-3.27%)
Jan 23, 2025, 8:27 AM BST
-64.25%
Market Cap 5.38M
Revenue (ttm) 1.14M
Net Income (ttm) -8.18M
Shares Out 632.43M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 20,000
Average Volume 372,579
Open 0.822
Previous Close 0.850
Day's Range 0.822 - 0.822
52-Week Range 0.800 - 2.200
Beta 2.97
RSI 49.44
Earnings Date May 1, 2025

About Kanabo Group

Kanabo Group Plc, a digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices. It operates through Primary Care and Secondary Care segments. The company offers The GP Service, an online telehealth platform, that provides patients with video consultations, online prescriptions, and primary care services; and operates Treat It, an online clinic focused on management of chronic pain. It also provides cultivation consultancy for cannabis businesses, as well... [Read more]

Sector Healthcare
Founded 2016
Employees 20
Stock Exchange London Stock Exchange
Ticker Symbol KNB
Full Company Profile

Financial Performance

In 2023, Kanabo Group's revenue was 895,000, an increase of 48.42% compared to the previous year's 603,000. Losses were -7.99 million, 16.3% more than in 2022.

Financial Statements

News

There is no news available yet.